期刊文献+

洗涤红细胞保护液肺动脉灌注对体外循环术后肺损伤的影响 被引量:3

Influence of pulmonary artery perfusion with solution of washed red blood cells on lung injury after cardiopulmonary bypass
原文传递
导出
摘要 目的观察心内直视手术中采用低温洗涤红细胞保护液肺动脉灌注对肺损伤的影响。方法选择风湿性二尖瓣病变伴中重度肺动脉高压(PH)的患者30例,分为肺动脉灌注组和对照组(各15例)。灌注组在升主动脉阻断后,经主肺动脉间断灌注低温洗涤红细胞保护液,测定并记录两组患者围术期的肺血管阻力(PVR)、静脉血与动脉血白细胞计数比值(V/A)、肺循环血浆丙二醛(MDA)含量及氧合指数(OI)、机械辅助通气时间。结果(1)PVR:转流结束即刻、术后12、24h灌注组(46·4kPa·s·L-1±8·1kPa·s·L-1、48·5kPa·s·L-1±7·0kPa·s·L-1、36·1kPa·s·L-1±6·3kPa·s·L-1)明显低于对照组(65·7kPa·s·L-1±5·3kPa·s·L-1、79·8kPa·s·L-1±8·7kPa·s·L-1、47·9kPa·s·L-1±7·1kPa·s·L-1,均P<0·05)。(2)MDA含量:转流结束即刻、术后12、24h灌注组(分别为14·3mmol/L±0·8mmol/L、16·1mmol/L±0·7mmol/L、13·3mmol/L±0·5mmol/L)明显低于对照组(18·9mmol/L±0·9mmol/L、21·6mmol/L±0·4mmol/L、22·5mmol/L±0·7mmol/L,均P<0·05)。(3)V/A比值:转流结束即刻、术后12h灌注组(1·16±0·05、1·20±0·05)明显低于对照组(1·53±0·07、1·68±0·25,均P<0·01)。(4)OI:转流结束即刻、术后12、24h灌注组(370±33、388±41、414±40)明显高于对照组(217±30、210±36、222±33,均P<0·05)。(5)机械辅助通气时间:灌注组(13h±4h)显著低于对照组(27h±6h,P<0·01)。结论洗涤红细胞保护液肺动脉灌注可以减轻体外循环术后肺损伤。 Objective To observe the influence of intra-operative pulmonary artery perfusion with hypothermic washed red blood cell ( RBC ) solution on lung injury after cardiopulmonary bypass ( CPB ). Methods Thirty patients of mitral disease with pulmonary hypertension undergoing mitral valve replacement were randomly divided into 2 equal groups: control group, and perfusion group ( with the pulmonary artery infused with 4℃ washed RBC protective solution during CPB). The blood cell count, pulmonary vascular resistance ( PVR), white blood cell (WBC) ratio ( venous blood/arterial blood), plasma malonyldialdehyde ( MDA), and oxygenation index (OI) , were measured and the time of mechanical ventilation was obtained aswell. Results (1) The PVR at the endofCPB, and 12 h and 24 h after CPB of the perfusiongroup were 46.4kPa·s·L^-1 ±8.1 kPa·s·L^-1,48.5 kPa·s·L^-1 ±7.0 kPa· s·L^-1, and 36.1 kPa·s ·L^ - 1 ± 6.3 kPa · s · L^ - 1 ) respectively, all significantly lower than those of the control group (65.7 kPa · s·L^-1±5.3kPa·s·L^-1,79.8kPa·s·L^-1 ±8.7kPa·s·L^-1,and47.9kPa·s·L^-1 ±7.1kPa· s · L^ - 1 respectively, all P 〈 0.05 ). ( 2 ) The levels of MDA at the end of CPB, and 12 h and 24 h after CPB of the perfusion group were 14.3 mmol/L ±0.8 mmol/L, 16.1 mmol/L ±0.7 mmol/L, and 13.3 mmol/L ±0.5 mmol/L respectively, all significantly lower than those of the control group ( 18.9 mmol/L ± 0.9 mmol/L, 21.6 mmol/L ±0.4 mmol/L, and 22.5 mmoL/L ± 0.7 mmol/L respectively, all P 〈 0.05 ). ( 3 ) The WBC ratios of vein and artery (V/A) a the end of CPB and 12 h after CPB of the perfusion group were 1.16 ±0.05 and 1.20 ±0.05 respectively, both significantly lower than those of the control group ( 1.53 ±0.07 and 1.68 ±0.25 respectively ( both P 〈0.01 ). (4) The OI at the end of CPB, and 12 h and 24 h after CPB of the perfusion group were 370 ±33,388 ±41, and 414 ±39 respectively, all significantly higher than those of the contr
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第20期1421-1424,共4页 National Medical Journal of China
关键词 再灌注损伤 肺动脉灌注 体外循环 肺损伤 Reperfusion injury Pulmonary artery perfusion Cardiopulmonary bypass Lung injury
  • 相关文献

参考文献10

二级参考文献26

  • 1郭峰.红细胞免疫研究概况[J].中华微生物学和免疫学杂志,1995,15(3):181-182. 被引量:78
  • 2高折益彦 柴田洋一.异体输血的副作用.自身输血[M].北京:人民军医出版社,1997.16-21. 被引量:12
  • 3Steinberg JB, Kapelanski DP, Olson JD. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1993, 106:1008-1016. 被引量:1
  • 4Gianetti J, Del Sarto P, Bevilacqua S, et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg, 2004, 127:44-50. 被引量:1
  • 5Holmes JH 4th, Connolly NC, Paull DL,et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res, 2002,51:579-586. 被引量:1
  • 6van Bommel EF, Hesse CJ, Jutte NH, et al. Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: a laboratory and clinical study.Contrib Nephrol,1995,16:62-75. 被引量:1
  • 7Uchino S, Bellomo R, Goldsmith D, et al. Cytokine removal with a large pore cellulose triacetate filter: an ex vivo study. Int J Artif Organs, 2002, 25:27-32. 被引量:1
  • 8Naik SK, Knigt A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion, 1991, 117:496-505. 被引量:1
  • 9Asimakopoulos G, Smith PLC, Ratnatunga CR, et al. Lung Injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg, 1999,68:1107-1115. 被引量:1
  • 10Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest, 1997,112:676-692. 被引量:1

共引文献36

同被引文献24

  • 1陈德容,卢淑玲,蔡任军.急性心肌梗塞时白细胞增多与预后关系的探讨[J].国际医药卫生导报,2004,10(16):80-81. 被引量:2
  • 2罗爱林,廖志品,田玉科.心肺转流心内直视术围术期血清重要炎性细胞因子水平变化与全身炎性反应综合征[J].临床麻醉学杂志,2005,21(12):806-808. 被引量:8
  • 3Blum A. White blood cell count and the coronary anatomy in acute coronary events[J]. AmJ Cardiol, 2005, 95. 159. 被引量:1
  • 4Kruk M, Karcz M, Przyluski J, et al. White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary pereutaneous coronary intervention (ANIN Myocardial Infarction Registry) [J]. Int J Cardiol, 2007, 116: 376. 被引量:1
  • 5Kojima S, Sakamoto T, Ishihara M, et al. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era[J]. Ann Med, 2004, 36: 153. 被引量:1
  • 6Pellizzon G G, Dixon S R, Stone G W, et al. Relation of admission white blood cell count to longterm outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial)[J]. Am J Cardiol, 2003, 91: 729. 被引量:1
  • 7Sabatine M S, Morrow D A, Cannon C P, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial)substudy[J]. J Am Coll Can:liol, 2002, 40: 1761. 被引量:1
  • 8Haim M, Boyko V, Goldbourt U, et al. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study[J]. Arch Intem Med, 2004, 164: 433. 被引量:1
  • 9Barron H V, Cannon C P, Murphy S A, et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy[J]. Circulation, 2000, 102: 2329. 被引量:1
  • 10Kurpesa M, Trzos E and Krzeminska-Pakula M. White blood cell count and the occurrence of silent ischemia after myocardial infarction [ J ]. Ann Noninvasive Electrocardiol, 2003, 8: 3. 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部